Proplatelet production and stromal fibrosis in myeloproliferative neoplasms

Leukemia Research

Volumn 34, Issue 11, 2010, Pages 1417-1419

  Wilkins, Bridget S ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bone marrow trephine; Histology; Immunohistochemistry; Megakaryocyte; Platelet; Proplatelet

Indexed keywords

CD61 ANTIGEN; GLYCOPROTEIN IB ALPHA;

BONE MARROW BIOPSY; BONE MARROW CANCER; CANCER CLASSIFICATION; CANCER MORPHOLOGY; CELL DENSITY; CELL FUNCTION; CELL JUNCTION; CONFOCAL MICROSCOPY; CYTOKINE RELEASE; EDITORIAL; HUMAN; IMMUNOHISTOCHEMISTRY; MEGAKARYOCYTE; MYELOID METAPLASIA; PATHOGENESIS; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTHEMIA; THROMBOCYTOPOIESIS; THROMBOCYTOSIS; TUMOR VASCULARIZATION; BONE MARROW EXAMINATION; MYELOPROLIFERATIVE DISORDER; PATHOLOGY; PATHOPHYSIOLOGY; STROMA CELL;

BONE MARROW EXAMINATION; HUMANS; MEGAKARYOCYTES; MYELOPROLIFERATIVE DISORDERS; PRIMARY MYELOFIBROSIS; STROMAL CELLS;

EID: 77957017732     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.07.010     Document Type: Editorial

References (20)

1. Muth M., Büsche G., Bock O., Hussein K., Kreipe H. Aberrant proplatelet formation in chronic myeloproliferative neoplasms. Leuk Res 2010, 34:1424-1429.
2. Thiele J., Kvasnicka H.M., Orazi A., Tefferi A., Gisslinger H. Essential thrombocythaemia. World Health Organization classification of tumours of haematopoietic and lymphoid tissue 2008, 48-50. IARC Press, Lyon. 4th ed. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
3. Thiele J., Kvasnicka H.M., Teferi A., Barosi G., Orazi A., Vardiman J.W. Primary myelofibrosis. World Health Organization classification of tumours of haematopoietic and lymphoid tissue 2008, 44-47. IARC Press, Lyon. 4th ed. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
4. Deutsch V.R., Tomer A. Megakaryocyte development and platelet production. Br J Haematol 2006, 134:453-466.
5. Kosaki G. In vivo platelet production from mature megakaryocytes: does platelet release occur via proplatelets?. Int J Hematol 2005, 81:208-219.
6. Kosaki G. Platelet production by megakaryocytes: proplatelet theory justifies cytoplasmic fragmentation moel. Int J Hematol 2008, 88:255-267.
7. Boveri E., Passamonti F., Rumi E., Pietra D., Elena C., Arcaini L., Pascutto C., Castello A., Cazzola M., Magrini U., Lazzarino M. Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations. Br J Haematol 2008, 140:162-169.
8. Medinger M., Skoda R., Gratwohl A., Theocharides A., Buser A., Heim D., Dirnhofer S., Tichelli A., Tzankov A. Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status. Br J Haematol 2009, 146:150-157.
9. Thiele J., Kvasnicka H.M., Werden C., Zankovich R., Diehl V., Fischer R. Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact. Leuk Lymphoma 1996, 22:303-317.
10. Kvasnicka H.M., Thiele J., Werden C., Zankovich R., Diehl V., Fischer R. Prognostic factors in idiopathic (primary) osteomyelofibrosis. Cancer 1997, 80:708-719.
11. Annaloro C., Lambertenghi Deliliers G., Oriani A., Pozzoli E., Lambertenghi Deliliers D., Radaelli F., Faccini P. Prognostic significance of bone marrow biopsy in essential thrombocytopenia. Haematologica 1999, 84:17-21.
12. Thiele J., Kvasnicka H.M. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG WHO) on 839 patients. Ann Hematol 2003, 82:148-152.
13. Thiele J., Kvasnicka H.M. Diagnostic differentiation of essential thrombocythaemia from thrombocythemias associated with chronic idiopathic myelofibrosis by discriminant analysis of bone marrow features - a clinicopathological study on 272 patients. Histol Histopathol 2003, 18:93-102.
14. Kreft A., Wiese B., Weiss M., Choritz H., Buhr T., Büsche G., Georgii A. Analysis of risk factors of the evolution of myelofibrosis in pre-fibrotic chronic idiopathic myelofibrosis: a retrospective study based on follow up biopsies of 70 patients by using the RECPAM method. Leuk Lymphoma 2004, 45:553-559.
15. Wilkins B.S., Erber W.N., Bareford D., Buck G., Wheatley K., East C.L., Paul B., Harrison C.N., Green A.R., Campbell P.J. Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes. Blood 2008, 111:60-70.
16. Campbell P.J., Bareford D., Erber W.N., Wilkins B.S., Wright P., Buck G., Wheatley K., Harrison C.N., Green AR Reticulin accumulation in essential thrombocythaemia: prognostic significance and relationship to therapy. J Clin Oncol 2009, 27:2991-2999.
17. Thiele J., Wagner S., Dienemann D., Wienhold S., Fischer R., Stein H. Megakaryocyte precursors (promegakaryoblasts and megakaryoblasts) in the normal human bone marrow. An immunohistochemical and morphometric study on routinely processed trephine biopsies. Anal Quant Cytol Histol 1990, 12:285-289.
18. Wilkins B.S., Harris S., Waseem N.H., Lane D.P., Jones D.B. A study of cell proliferation in formalin-fixed, wax-embedded bone marrow trephine biopsies using the monoclonal antibody PC10, reactive with proliferating cell nuclear antigen (PCNA). J Pathol 1992, 166:45-52.
19. Thiele J., Titius B.R., Kvasnicka H.M., Rechmeier W., Fischer R. Megakaryopoiesis in chronic myeloproliferative disorders: immunohistochemical evaluation of endoreduplicative activity by PCNA-staining reaction. Anal Cell Pathol 1994, 7:63-75.
20. Thiele J., Kvasnicka H.M., Diehl V., Fischer R., Michiels J. Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies. Leuk Lymphoma 1999, 33:207-218.